Idiopathic pulmonary fibrosis (IPF) and evidence-based guidelines
[ N/A ]
Date
2020
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Nova Science Publishers, Inc.
Access Rights
info:eu-repo/semantics/closedAccess
Abstract
Idiopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic, progressive fibrosing interstitial pneumonia of unknown cause. The first guideline on IPF management, published in 2000, is based on the consensus of an international group of experts in the field. The guideline, created by hard work by the American Thoracic Society (ATS), European Respiratory Society (ERS), Japanese Respiratory Society (JRS), and Latin American Thoracic Society (ALAT) in 2011, reviewed all available evidence, clarified the definition of IPF, provided precise diagnostic criteria, described the natural course of the disease, and provided evidence-based recommendations for treatment. In 2015, recommendations for the treatment of IPF were updated on the basis of new scientific evidence. No pharmacological intervention has received strong recommendations for treatment. Clinicians should make individualized decisions based on conditional recommendations in the treatment of patients with IPF. © 2020 Nova Science Publishers, Inc.
Description
Keywords
Journal or Series
Respiratory Ventilatory Strategies in Acute and Chronic Respiratory Failure in Idiopathic Pulmonary Diseases: A Practical Approach
WoS Q Value
Scopus Q Value
N/A
